Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Silo Pharma (SILO) FCF Margin (2016 - 2025)

Historic FCF Margin for Silo Pharma (SILO) over the last 11 years, with Q3 2025 value amounting to 5300.93%.

  • Silo Pharma's FCF Margin rose 21692500.0% to 5300.93% in Q3 2025 from the same period last year, while for Sep 2025 it was 6655.15%, marking a year-over-year decrease of 13480900.0%. This contributed to the annual value of 5317.35% for FY2024, which is 8452100.0% down from last year.
  • Silo Pharma's FCF Margin amounted to 5300.93% in Q3 2025, which was up 21692500.0% from 7130.47% recorded in Q2 2025.
  • Over the past 5 years, Silo Pharma's FCF Margin peaked at 471872.56% during Q4 2021, and registered a low of 9099.63% during Q1 2025.
  • Over the past 5 years, Silo Pharma's median FCF Margin value was 4649.83% (recorded in 2024), while the average stood at 27951.9%.
  • As far as peak fluctuations go, Silo Pharma's FCF Margin soared by 2000000000bps in 2021, and later crashed by 2000000000bps in 2022.
  • Over the past 5 years, Silo Pharma's FCF Margin (Quarter) stood at 471872.56% in 2021, then tumbled by -101bps to 4915.06% in 2022, then decreased by -3bps to 5048.33% in 2023, then decreased by -1bps to 5089.49% in 2024, then decreased by -4bps to 5300.93% in 2025.
  • Its FCF Margin stands at 5300.93% for Q3 2025, versus 7130.47% for Q2 2025 and 9099.63% for Q1 2025.